JHU In Vivo Cellular and Molecular Imaging Center, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Curr Opin Support Palliat Care. 2011 Dec;5(4):327-33. doi: 10.1097/SPC.0b013e32834c49ba.
One of the most under explored and yet devastating consequences of cancer is cachexia, a condition in which the body is consumed by deranged carbohydrate, lipid and protein metabolism that is induced by inflammatory cytokines. Cachexia is associated with poor treatment outcome, fatigue and poor quality of life. Because of its multifactorial characteristics, it has been difficult to understand the impact of the tumor on body organs and the sequence of events that leads to cachexia. Such insights are critically important in identifying therapeutic strategies.
The ability to understand the interaction between the tumor and normal tissues and to noninvasively image the development of this condition would be invaluable in identifying critical stages when cachexia becomes life-threatening. Current multimodality molecular and functional imaging capabilities provide unique opportunities to study cachexia holistically in preclinical models and clinically. In this review we have provided examples of how state-of-the-art imaging techniques in combination with molecular characterization can be used to understand cancer-induced cachexia.
Such studies will lead to clinically translatable indices for the early detection of this condition and will identify novel targets to inhibit the cachexia cascade.
癌症最未被充分研究但却极具破坏性的后果之一是恶病质,这是一种由炎症细胞因子引起的碳水化合物、脂肪和蛋白质代谢紊乱导致身体消耗的疾病。恶病质与治疗效果不佳、疲劳和生活质量差有关。由于其多因素的特点,人们一直难以理解肿瘤对身体器官的影响以及导致恶病质的一系列事件。这种深入了解对于确定治疗策略至关重要。
了解肿瘤与正常组织之间的相互作用,并能够对这种情况的发展进行非侵入性成像,对于确定恶病质变得危及生命的关键阶段将是非常宝贵的。目前的多模态分子和功能成像能力为在临床前模型和临床中全面研究恶病质提供了独特的机会。在这篇综述中,我们提供了一些例子,说明如何结合分子特征使用最先进的成像技术来理解癌症引起的恶病质。
此类研究将为早期发现这种疾病提供具有临床转化价值的指标,并确定抑制恶病质级联反应的新靶点。